Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 25c, Beats on Revenue; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
BofA Securities Upgrades Zimmer Biomet (ZBH) to Neutral (Tuesday)
May 3, 2023 9:14 AM EDTBofA Securities analyst Travis Steed upgraded Zimmer Biomet (NYSE: ZBH) from Underperform to Neutral with a price target of $160.00 (from $120.00).
For an analyst ratings summary and ratings history on Zimmer Biomet click here. For more ratings news on Zimmer Biomet click here.
Shares of Zimmer Biomet closed at $143.01 yesterday.
... More


